IL15 and neutropenia: All the patients treated with the highest dose of rhIL15 developed liver damage and lymphopenia; in some cases associated with thrombocytopenia, anemia or neutropenia, indicating that our data somehow mimic the effect of IL-15 in patients, probably being more dramatic due to the sustained exposure to the cytokine.